PerformanceSLU-PP 332
5MG
$85
Description
SLU-PP 332 is a novel exercise mimetic compound developed at Saint Louis University that activates estrogen-related receptors (ERRs), particularly ERR-alpha, ERR-beta, and ERR-gamma. These nuclear receptors are master regulators of mitochondrial biogenesis, oxidative metabolism, and endurance capacity — the same pathways activated by physical exercise. SLU-PP 332 essentially triggers many of the cellular adaptations that occur with endurance training, including increased mitochondrial content, enhanced fatty acid oxidation, and improved muscle fiber composition, without requiring physical activity. This makes it a groundbreaking tool for studying exercise physiology and metabolic adaptation.
Potential Benefits
Research Notes
Published in the Journal of Pharmacology and Experimental Therapeutics, research by Dr. Thomas Bhurr at Saint Louis University demonstrates SLU-PP 332's ability to activate all three ERR subtypes, resulting in increased expression of genes involved in mitochondrial biogenesis, fatty acid metabolism, and oxidative phosphorylation. Animal studies showed improved running endurance and fatigue resistance, with a shift toward oxidative muscle fiber types.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.